Function of a HER2 VUS in colorectal cancer with APC mutations and its potential for HER2-targeted therapy

被引：0
|
作者：
Mitani, Yosuke [1 ]
Ohashi, Shinya [1 ]
Kikuchi, Osamu [1 ]
Muto, Manabu [1 ]
机构：
[1] Kyoto Univ, Dept Therapeut Oncol, Kyoto, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.378
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P34-6
引用
收藏
页码：S1455 / S1455
页数：1
相关论文
共 50 条
  • [41] TNFα induces multiresistance to HER2-targeted TNFα induces multiresistance to HER2-targeted therapies in HER2-positive breast cancer
    Mercogliano, Maria F.
    De Martino, Mara
    Bruni, Sofia
    Venturutti, Leandro
    Rivas, Martin
    Amasino, Matias
    Proietti, Cecilia J.
    Elizalde, Patricia V.
    Schillaci, Roxana
    CANCER RESEARCH, 2017, 77
  • [42] Her2 a paradigm for targeted therapy
    Marijon, Helene
    Andre, Fabrice
    BULLETIN DU CANCER, 2011, 98 (09) : 1011 - 1017
  • [43] Development of HER2 targeted therapy
    Tamura, Kenji
    CANCER SCIENCE, 2021, 112 : 158 - 158
  • [44] The role of HER2 alterations in clinicopathological and molecular characteristics of breast cancer and HER2-targeted therapies: a comprehensive review
    Asgari-Karchekani, Shafighe
    Aryannejad, Armin
    Mousavi, Seied Asadollah
    Shahsavarhaghighi, Shirin
    Tavangar, Seyed Mohammad
    MEDICAL ONCOLOGY, 2022, 39 (12)
  • [45] HER2-Targeted Affibody Molecule 99mTc-ABH2 for Imaging HER2 Expression in Breast Cancer
    Jin, Xiaona
    Zhang, Yuwei
    Cao, Xi
    Wang, Peipei
    Ren, Chao
    Cai, Jiong
    Wang, Xuefei
    Jing, Hongli
    Sun, Qiang
    Li, Fang
    CLINICAL NUCLEAR MEDICINE, 2025, 50 (01) : 25 - 30
  • [46] HER2 Activating Mutations Are Targets for Colorectal Cancer Treatment
    Kavuri, Shyam M.
    Jain, Naveen
    Galimi, Francesco
    Cottino, Francesca
    Leto, Simonetta M.
    Migliardi, Giorgia
    Searleman, Adam C.
    Shen, Wei
    Monsey, John
    Trusolino, Livio
    Jacobs, Samuel A.
    Bertotti, Andrea
    Bose, Ron
    CANCER DISCOVERY, 2015, 5 (08) : 832 - 841
  • [47] Cerebrospinal Fluid Testing in Leptomeningeal Progression of HER2-Negative Breast Cancer Reveals HER2 Positivity, Leading to HER2-Targeted Therapy: A Case Report
    Choi, Seraphina
    Cassidy, Daniel
    Castillo, Patricia
    Mellon, Eric A.
    Calfa, Carmen
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [48] The role of HER2 alterations in clinicopathological and molecular characteristics of breast cancer and HER2-targeted therapies: a comprehensive review
    Shafighe Asgari-Karchekani
    Armin Aryannejad
    Seied Asadollah Mousavi
    Shirin Shahsavarhaghighi
    Seyed Mohammad Tavangar
    Medical Oncology, 39
  • [49] Role of Fcγ receptors in HER2-targeted breast cancer therapy
    Musolino, Antonino
    Gradishar, William J.
    Rugo, Hope S.
    Nordstrom, Jeffrey L.
    Rock, Edwin P.
    Arnaldez, Fernanda
    Pegram, Mark D.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (01)
  • [50] History and Future of HER2-Targeted Therapy for Advanced Gastric Cancer
    Ariga, Shin
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (10)
12345